119 related articles for article (PubMed ID: 8043542)
1. Five year survival rate in endometrial carcinoma stages I--II: influence of degree of tumour differentiation, age, myometrial invasion and DNA content.
Lindahl B; Ranstam J; Willén R
Br J Obstet Gynaecol; 1994 Jul; 101(7):621-5. PubMed ID: 8043542
[TBL] [Abstract][Full Text] [Related]
2. Endometrial carcinoma: results of primary surgery on FIGO stages Ia-Ic and predictive value of histopathological parameters.
Lindahl B; Einarsdottir M; Iosif C; Ranstam J; Willén R
Anticancer Res; 1997; 17(3C):2297-302. PubMed ID: 9216705
[TBL] [Abstract][Full Text] [Related]
3. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
4. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
[TBL] [Abstract][Full Text] [Related]
5. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
[TBL] [Abstract][Full Text] [Related]
6. The significance of the degree of myometrial invasion in patients with stage IB endometrial cancer.
Gemer O; Uriev L; Harkovsky T; Peled R; Ben-Dor D; Barak F; Segal S
Eur J Gynaecol Oncol; 2004; 25(3):336-8. PubMed ID: 15171313
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the depth of myometrial invasion in stage I endometrioid endometrial cancer using pancytokeratin immunohistochemistry.
Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
Int J Gynecol Cancer; 2004; 14(4):665-72. PubMed ID: 15304163
[TBL] [Abstract][Full Text] [Related]
8. Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway.
Ørbo A; Rydningen M; Straume B; Lysne S
Int J Gynecol Cancer; 2002; 12(1):49-56. PubMed ID: 11913358
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II.
Wagenius G; Bergström R; Strang P; Gerdes U; Rogo K; Tribukait B; Stendahl U
Anticancer Res; 1992; 12(3):725-32. PubMed ID: 1622130
[TBL] [Abstract][Full Text] [Related]
10. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion.
Longacre TA; Hendrickson MR
Am J Surg Pathol; 1999 Jan; 23(1):69-78. PubMed ID: 9888705
[TBL] [Abstract][Full Text] [Related]
11. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of myometrial invasion in endometrial carcinoma.
Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
Friberg LG; Norén H; Delle U
Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
[TBL] [Abstract][Full Text] [Related]
14. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
15. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
[TBL] [Abstract][Full Text] [Related]
16. Value of the intraoperative assessment of the depth of myometrial invasion in endometrial carcinoma.
Obrzut B; Obrzut M; Skret-Magierło J; Skret A; Ulman D; Król P; Zmuda M
Ginekol Pol; 2008 Jun; 79(6):404-9. PubMed ID: 18652127
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of extra-uterine involvement and prognosis in young type I endometrial carcinoma with high or moderate differentiation and less than 1/2 myometrial invasion.
Sun Y; Han P; Wang Y; Cheng X; Wu W; Liu Q; Ren F
Aging (Albany NY); 2024 Apr; 16(7):6445-6454. PubMed ID: 38575312
[TBL] [Abstract][Full Text] [Related]
18. Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.
Alexander-Sefre F; Salvesen HB; Ryan A; Singh N; Akslen LA; MacDonald N; Wilbanks G; Jacobs IJ
Gynecol Oncol; 2003 Oct; 91(1):218-25. PubMed ID: 14529685
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
